Author

Ling-Dong Kong

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

FBP1‐Mediated Compartmentalization of Glycolytic Enzyme Complexes Suppresses PKM2 Function to Ameliorate MASLD Progression

It is shown that FBP1 is consistently downregulated during MASLD progression, with a progressive decline from MASL to MASH in clinical specimens and key preclinical models, and the FBP1‐PKM2 interaction is identified as a novel candidate intervention target for MASLD.

Bu-Song Wang, Yi-Ping Tang, Na Li et al. · Advancement of science · 0 citations

#protein folding Open access Oct 2026

Taxifolin alleviates podocyte injury and macrophage chemotaxis associated with diabetic nephropathy by directly targeting RBP1 identified via multi-omics and machine learning

The identification of RBP1 as a novel driver of podocyte injury and macrophage chemotaxis associated with DN via multi-omics and machine learning and the potential of taxifolin as a targeted intervention for DN progression are supported.

Zi-Xuan Wang, Wen-Xuan Wang, Qiong-Dan Liang et al. · Frontiers in Pharmacology · 0 citations